Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee
- 216 Downloads
The pathogenesis behind osteonecrosis of the knee is still unknown. Circulatory impairment of the bone secondary to thrombosis in the microcirculation has been suggested as a mechanism. The purpose of this study was to examine the association between osteonecrosis of the knee and abnormalities in the thrombotic pathway in the form of factor V Leiden and the prothrombin 20210A gene mutation.
Materials and methods
Thirty-eight consecutive patients (13 men and 25 women) with osteonecrosis of the knee without a history of knee trauma or surgery to the knee were enrolled in this study. Assays for the detection of factor V Leiden and the prothrombin 20210A gene mutation were performed, and the results were compared with those from 282 healthy volunteers.
Six patients were diagnosed with secondary osteonecrosis, four corticosteroid-induced and two alcohol-induced. In 32 patients, no aetiological factor was found, and these patients were diagnosed with primary osteonecrosis of the knee. Twelve patients had 14 gene mutations, 11 factor V Leiden and 3 prothrombin 20210A gene mutations. Factor V Leiden and the prothrombin 20210A gene mutation occurred significantly (p=0.006) more frequently in patients with osteonecrosis than in a population of 282 healthy volunteers (odds ratio 3.1, 95%CI 1.4–6.6).
The results of this study suggest that coagulation abnormalities in the form of factor V Leiden and the prothrombin 20210A gene mutation might play a role in osteonecrosis of the knee.
KeywordsOsteonecrosis Knee Factor V Leiden Prothrombin gene
This study was supported by grants from Herman Järnhardts Foundation. The above study complies with the current laws of Sweden.
- 7.Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL (2001) Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism: pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost 86:809–816PubMedGoogle Scholar
- 12.Hirota Y, Hotokebuchi T, Sugioka Y (1997) Idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Urbaniak JR, Jones JP Jr (eds) Osteonecrosis: etiology, diagnosis and treatment. American Academy of Orthopaedic Surgeons, Rosemont, pp 51–58Google Scholar
- 13.Hresko T, McDougall PA, Gorlin JB, Vamvakas EC, Kasser JR, Neufeld EJ (2002) Prospective reevaluation of the association between thrombotic diathesis and Legg-Perthes disease. J Bone Joint Surg Am 84:1613–1618Google Scholar
- 15.Kirkwood BR (1988) Cohort and case-control studies. In: Kirkwood BR (ed) Essentials of medical statistics. Blackwell Scientific Publications, Oxford, pp 177–183Google Scholar
- 16.Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rayadhyaksha A, Urbaniak JR (2002) Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am 84:834–853Google Scholar
- 17.Lotke PA (1997) Tibial osteonecrosis. In: Urbaniak JR, Jones JP Jr (eds) Osteonecrosis: etiology, diagnosis and treatment. American Academy of Orthopaedic Surgeons, Rosemont, pp 425–428Google Scholar
- 21.Mont MA, Rifai A, Baumgarten KM, Sheldon M, Hungerford DS (2002) Total knee arthroplasty for osteonecrosis. J Bone Joint Surg Am 84:599–603Google Scholar
- 24.Robertsson O, Dunbar MJ, Knutsson K, Lidgren L (2000) Past incidence and future demand for knee arthroplasty in Sweden. A report from the Swedish knee arthroplasty register regarding the effect of past and future population changes on the number of athroplasties performed. Acta Orthop Scand 71:376–380CrossRefPubMedGoogle Scholar